Community Action Marin
Kawa C. serves as Chief Technical Officer at Abdera Therapeutics, overseeing the CMC development of the targeted radiopharmaceutical therapy ABD-147, which received FDA clearance for its IND in May 2024. Additionally, Kawa C. holds a position as an Executive Committee Board Member for Community Action Marin, promoting equity and support for underserved families. Previously, Kawa C. was a Board Member of the Marin Health Council, advising on health resources and education, and Vice President of CMC, Manufacturing Systems and Supply Chain at Lyell Immunopharma, where three successful IND approvals were achieved. Kawa C. also worked at Genentech as Global Head of Product Supply Chain Planning, leading transformation projects for a $46 billion biologics portfolio. Educational background includes a Master of Public Health from the University of California, Berkeley, and a Master of Science in Engineering from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Community Action Marin
Community Action Marin is a 501(c)(3) non-profit anti-poverty social services agency that helps people throughout Marin County achieve self-sufficiency and thrive. At Community Action Marin, we make it possible for people in Marin to achieve well-being by providing the vital services they need. Together, we break down the barriers that get in the way of fair and lasting change in service to better outcomes for all.